Can I read Novel Therapeutic Targets for Antiarrhythmic Drugs on EtoBox?

Novel Therapeutic Targets for Antiarrhythmic Drugs by Billman, George Edward is a scholarly article available to read on EtoBox.

What is Novel Therapeutic Targets for Antiarrhythmic Drugs about?

PROFILES POTENTIAL TREATMENT APPROACHES FOR CARDIAC ARRHYTHMIAS Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections: Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. Section Two addresses safety pharmacology, including the concept of'repolarization reserve,'sa

Author

Billman, George Edward

Publisher

John Wiley & Sons, Incorporated

Published

2009

Language

EN

ISBN

9780470561416